Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alto Neuroscience (ANRO) Cash from Operations (2023 - 2026)

Alto Neuroscience has reported Cash from Operations over the past 4 years, most recently at 27091000.0 for Q1 2026.

  • Quarterly results put Cash from Operations at 27091000.0 for Q1 2026, down 63.63% from a year ago — trailing twelve months through Mar 2026 was 62304000.0 (down 17.56% YoY), and the annual figure for FY2025 was 51769000.0, down 9.16%.
  • Cash from Operations reached 27091000.0 in Q1 2026 per ANRO's latest filing, down from 11516000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 6635000.0 in Q2 2023 and bottomed at 27091000.0 in Q1 2026.
  • Median Cash from Operations over the past 4 years was 11524000.0 (2023), compared with a mean of 12287076.92.
  • The largest annual shift saw Cash from Operations tumbled 76.25% in 2024 before it grew 15.42% in 2025.
  • Over 4 years, Cash from Operations stood at 11524000.0 in 2023, then decreased by 12.99% to 13021000.0 in 2024, then increased by 11.56% to 11516000.0 in 2025, then crashed by 135.25% to 27091000.0 in 2026.
  • Business Quant data shows Cash from Operations for ANRO at 27091000.0 in Q1 2026, 11516000.0 in Q4 2025, and 9918000.0 in Q3 2025.